Functional diagnosis of chronic obstructive pulmonary disease;La diagnosi funzionale della broncopneumopatia cronica ostruttiva

Annali dell'Istituto Superiore di Sanita

Volumn 39, Issue 4, 2003, Pages 529-547

  Ciappi, Giuliano ^a   Corbo, Giuseppe ^a   Valente, Salvatore ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Airflow limitation; Chronic obstructive pulmonary disease; Diagnosis; Forced expiratory volume in one second; Forced expiratory volume in one second forced vital capacity; Forced vital capacity; Spirometry

Indexed keywords

AIRWAY OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HUMAN; PATIENT MONITORING; REHABILITATION MEDICINE; REVIEW; SPIROMETRY;

BRONCHIAL PROVOCATION TESTS; EXERCISE TOLERANCE; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY GAS EXCHANGE; RESPIRATORY MECHANICS;

EID: 1842532921     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Quanjer PhH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party. Standardization of lung function tests. Official statement of the European Respiratory Society. Eur Respir J 1993;6(suppl. 16):5-40.
2. Mead J, Turner JM, Macklem PT, Little JB. Significance of the relationship between lung elastic recoil and maximum expiratory flow. J Appl Physiol 1967;22:95-108.
3. Froeb HF, Mead J. Relative hysteresis of the dead space and lung in vivo. J Appl Physiol 1968;25:244-8.
4. Rodenstein DO, Stanescu DC. Reassessment of lung volume measurement by helium dilution and body plethysmography in chronic airflow obstruction. Am Rev Respir Dis 1982;126:1040-4.
5. Dawson A. Elastic recoil and compliance. In: Pulmonary function testing. Guidelines and controversies. Clausen J. (Ed.). USA: Grune & Stratton; 1984. p. 193-204.
6. Miller WF, Scacci R, Gast LR. Mechanics of breathing. In: Laboratory evaluation of pulmonary function. USA: Lippincott; 1987. p. 176-235.
7. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS. On behalf of the GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1256-76.
8. Dawson SV, Elliott EA. Wave-speed limitation on expiratory flow. A unifying concept. J Appl Physiol 1977;43:498-515.
9. Berry RB, Fairshter RD. Partial and maximal expiratory flow-volume curves in normal and asthmatic subjects before and after inhalation of metaproterenol. Chest 1985;88:697-702.
10. Pellegrino R, Rodarte JR, Brusasco V. Assessing the reversibility of airway obstruction. Chest 1998;114:1607-12.
11. Ingram RH, Schilder DP. Effect of thoracic gas compression on the flow-volume curve of the forced vital capacity. Am Rev Respir Dis 1966;94:56-63.
12. Fairshter RD, Berry RB, Wilson AF, Brideshead T, Mukai D. Effects of thoracic gas compression on maximal and partial flow-volume maneuvers. J Appl Physiol 1989;67:780-5.
13. Pellegrino R, Confessore P, Bianco A, Brusasco V. Effects of lung volume and thoracic gas compression on maximal and partial flow-volume curves. Eur Respir J 1996;9:2168-73.
14. Koulouris NG, Valta P, Lavoie A, Corbeil C, Chassé M, Braidy J, Milic-Emili J. A simple method to detect expiratory flow limitation during spontaneous breathing. Eur Respir J 1995;8:306-13.
15. Hadcroft J, Calverley PMA. Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease. Thorax 2001;56:713-20.
16. Neuburger N, Levison H, Kruger K. Transit time analysis of the forced expiratory vital capacity in cystic fibrosis. Am Rev Respir Dis 1976;114:753-9.
17. Woolcock AJ, Vincent NJ. Macklem PT. Frequency dependence of compliance as a test for obstruction in the small airways. J Clin Invest 1969;48:1097-106.
18. Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes D. Two-, six-, and twelve-minute walking tests in respiratory disease. BMJ 1982;284:1607-8.
19. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998;158:1384-7.
20. Demedts M. Precise diagnosis of airflow obstruction - does it matter for treatment? The assessment of reversibility: what physiological tests? Eur Respir J 1990;3:1084-7.
21. Pennock BE, Rogers RM, McCaffree DR. Changes in measured spirometric indices. What is significant? Chest 1981;80:97-9.
22. British Thoracic Society. Guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52:S1-S27.
23. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Resp Dis 1991;144:1202-18.
24. Brand PL, Quanjer PH, Postma DS, Kerstjens HA, Koeter GH, Dekhuijzen PN, Sluiter HJ. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax 1992;47:429-436.
25. Eliasson O, Degraff AC. The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables. Am Rev Respir Dis 1985:132:858-64.
26. 1. Eur Respir J 1992;5:975-81.
27. Meslier N, Racineux JL, Six P, Lockhart A. Diagnostic value of reversibility of chronic airway obstruction to separate asthma from chronic bronchitis: a statistical approach. Eur Respir J 1989;2:497-505.
28. Kesten S, Rebuck AS. Is the short-term response to inhaled beta-adrenergic agonist sensitive or specific for distinguishing between asthma and COPD? Chest 1994;105:1042-5.
29. Sasaki H, Hoppin FG. Hysteresis of contracted airway smooth muscle. J Appl Physiol 1979;47:1251-62.
30. Fairshter RD. Airway hysteresis in normal subjects and individuals with chronic airflow obstruction. J Appl Physiol 1985;58:1505-10.
31. Wang YT, Thompson LM, Ingenito EP, Ingram RH. Effects of increasing doses of beta-agonists on airway and parenchymal hysteresis. J Appl Physiol 1990;68:363-8.
32. Pellegrino R, Brusasco V. Lung hyperinflation and flow limitation in chronic airway obstruction. Eur Respir J 1997;10:543-9.
33. van Noord JA, Smeets J, Clement J, Van de Woestijne KP, Demedts M. Assessment of reversibility of airflow obstruction. Am J Respir Crit Care Med 1994;150:551-4.
34. Cerveri I, Pellegrino R, Dore R, Corsico A, Fulgoni P, Van de Woestijne KP, Brusasco V. Mechanisms for isolated volume response to a bronchodilator in patients with COPD. J Appl Physiol 2000;88:1989-95.
35. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:770-7.
36. Girard WM, Light RW. Should the FVC be considered in evaluating response to bronchodilator? Chest 1983;84:87-9.
37. 1 during long-term inhaled corticosteroid treatment. Eur Respir J 1993;6:868-76.
38. Papi A, Romagnoli M, Baraldo S, Braccioni F, Guzzinati I, Saetta M, Ciaccia A, Fabbri LM. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162:1773-7.
39. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986;133:14-20.
40. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS, Tashkin DP. Smoking cessation and the lung function in mild-to-moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:381-90.
41. Hansen EF, Pharareth K, Laursen LC, Kok-Jensen A, Dirken A. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1267-71.
42. DeJong JW, Koeter GH, Postma DS. The significance of airway responsiveness in the onset and evolution of chronic obstructive pulmonary disease. Clin Exp Allergy 1997;27:1114-9.
43. Vestbo J, Hansen EF. Airway hyperresponsiveness and COPD mortality. Thorax 2001;56(Suppl):11-4.
44. Postma DS, Kerstjens HAM. Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:S187-92.
45. Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O'Byrne PM, Anderson SD, Juniper EF, Malo JI. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993;16:53-83.
46. Tashkin DP, Altose MD, Connett JE, Kanner RE, Lee WW, Wise RA. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:1802-11.
47. Finkelstein R, Ghjezzo H, Whittaker K, Fraser RS, Cosio MG. Morphometry of small airways in smokers and its relationship to emphysema type and hyperresponsiveness. Am J Respir Crit Care Med 1995;152:267-76.
48. Oosterhoff Y, deJong JW, Jansen MA, Koeter GH, Postma DS. Airway responsiveness to adenosine-5′-monophosphate in chronic obstructive pulmonary disease is determined by smoking Am Rev Respir Dis 1993;147:553-8.
49. Xu X, Rijcken B, Scouten JP, Weiss ST. Airways responsiveness and development and remission of chronic respiratory symptoms in adults. Lancet 1997;350:1431-4.
50. Hospers JJ, Postma DS, Rijcken B, Weiss ST, Schouten JP. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet 2000;356:1313-7.
51. West JB. Ventilation-perfusion inequality and overall gas exchange in computer models of the lungs. Resp Physiol 1969;7:88.
52. Farhi LE. Ventilation-perfusion relationship and its role in alveolar gas exchange. In: Caro CG (Ed.). Advances in respiratory physiology. London: Edward Arnold Publ.; 1966. p. 148-197.
53. Sorbini CA, Grassi V, Solinas E, Muiesan G. Arterial oxygen tension in relation to age in healthy subjects. Respiration 1968;25:3-13.
54. Riley RL, Cournand A, Donald KW. Analysis of factors affecting partial pressures of oxygen and carbon dioxide in gas and blood of lungs. Methods. J Appl Physiol 1951;4:102-20.
55. Farhi LE. Elimination of inert gas by the lung. Resp Physiol 1967;3:1-11.
56. Farhi LE, Yokoyama T. Effects of ventilation-perfusion inequality on elimination of inert gases. Resp Physiol 1997;3:12-20.
57. Bergofsky EH. Mechanisms underlying vasomotor regulation of regional pulmonary blood flow in normal and disease states. Am J Med 1974;57:378.
58. Dantzker DR. Tissue oxigen delivery. In: Dantzker DR, MacIntyre NR, Bakow ED (Ed.). Comprehensive respiratory care. Philadelphia: W.B. Saunders Publ.; 1995. p. 156-171
59. Thompson CS. Acid-base disorders and electrolyte imbalance. In: Dantzker DR, MacIntyre NR, Bakow ED (Ed.). Comprehensive respiratory care. Philadelphia: W.B. Saunders Publ.; 1995. p. 70-97.
60. Wagner PD, Salzman HA, West JB. Measurement of continuous distribution of ventilation-perfusion ratios. J Appl Physiol 1974;36:588.
61. Wagner PD, Dantzker DR, Dueck R, Clausen JL, West JB. Ventilation-perfusion inequality in chronic obstructive pulmonary disease. J Clin Invest 1977;59:203.
62. Roughton FJW. Forster RE. Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung. J Appl Physiol 1957;11:290-302.
63. Wagner PD. Diffusion and chemical reaction in pulmonary gas exchange. Physiol Rev 1977;57:257-312.
64. Maclntyre NR. Diffusing capacity of the lung for carbon monoxide. Respir Care Clin N Am 1997;3:221-33.
65. Baldi S, Miniati M, Bellina CR, Battolla L, Catapano G, Begliomini E, Giustini D, Giuntini C. Relationship between extent of pulmonary emphysema by high-resolution computed tomography and elastic lung recoil in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:585-9.
66. Morrison NJ, Abboud RT, Ramadan F, Miller RR, Gibson NN, Evans KG, Nelems B, Muller NL. Comparison of single breath carbon monoxide diffusing capacity and pressure-volume curves in detecting emphysema. Am Rev Respir Dis 1989;139:1179-87.
67. Beck KC, Offord KP, Scanlon PD. Comparison of four methods for calculating diffusing capacity by the single-breath method. Chest 1994;105:594-600.
68. Paoletti P, Di Pede F, Fazzi P. Giuntini C. Reference equation for the single-breath diffusing capacity: a cross-sectional analysis and effect of body size and age. Am Rev Respir Dis 1985;132:806-13.